Antibodies
10 December 2007
Pivotal Phase 3 NPLATE(TM) Study in Non-Splenectomized Patients Met Primary Endpoints10 December 2007
Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin’s Lymphoma10 December 2007
Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma10 December 2007
Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)9 December 2007
ImmunoGen, Inc. Announces Encouraging Clinical Findings Reported at ASH Annual Meeting for TAP Compound AVE96336 December 2007
Raven biotechnologies, Inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies5 December 2007
Genentech Provides Update From Avastin FDA Advisory Meeting5 December 2007
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer4 December 2007
Arana Announces Phase II Trials For Lead Compound ART6214 December 2007
Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-13423 December 2007
“Actemra(R),” a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody, Filed for Rheumatoid Arthritis in Europe2 December 2007
Novartis further strengthens biologics capabilities in expansion of MorphoSys collaboration29 November 2007
New Data Highlight That Treatment With Erbitux Allows More Resections of Preteated Patients With Metastatic Colorectal Cancer29 November 2007
Regeneron Initiates Major Global Collaboration with Sanofi-aventis to Develop and Commercialize Fully-Human Therapeutic Antibodies28 November 2007
MediGene and Celltrion Announce Co-development of Anti-L1 Monoclonal Antibody Therapeutic for Treating Cancer26 November 2007
MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis21 November 2007
Roche Submits Application for FDA Approval of Actemra for the Treatment of Rheumatoid Arthritis21 November 2007
Kyto Biopharma Inc. Confirms Definitive Isolation of the Human Vitamin B12 Receptor (TCblR)News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe![Newsletter La Merie Biologics](https://pipelinereview.com/wp-content/uploads/2024/02/newsletter-1.png)
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe![Newsletter new product alert](https://pipelinereview.com/wp-content/uploads/2024/02/report-alert.png)
Featured reports